866-997-4948(US-Canada Toll Free)

Baxter International Inc. (BAX) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 43 Pages


Baxter International Inc. (Baxter) is a globally diversified healthcare company. It undertakes the development, manufacture and marketing of medical products, which save and sustain the lives of people. The company's products assist healthcare professionals and their patients in the treatment of complex medical conditions such as hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It conducts operations in North America, Latin America, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, the US.

The company seeks to maintain a leading position in the global healthcare market through acquisitions, partnerships and strategic alliances. In line with this strategy, Baxter acquired Synovis Life Technologies, Inc., Baxa Corporation, and Prism Pharmaceuticals, Inc., and entered into strategic agreement with Momenta Pharmaceuticals, Inc. to develop and commercialize follow-on biologic products.

This report is a source for data, analysis and actionable intelligence on the Baxter International Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.

Table of Contents 2
List of Tables 3
List of Figures 4
Baxter International Inc. - Business Description 5

Key Facts 6
Baxter International Inc. - Major Products and Services 7
Baxter International Inc. Pipeline Products by Equipment Type 8
Baxter International Inc. Pipeline Products by Development Stage 10
Baxter International Inc. Pipeline Products by Trial Phase 12
Baxter International Inc. Pipeline Products by Milestone Summary 13
Nocturnal Home Hemodialysis System 15
Nocturnal Home Hemodialysis System Product Status 15
Nocturnal Home Hemodialysis System Product Description 15
Nocturnal Home Hemodialysis System Product Milestone 15
Nocturnal Home Hemodialysis System Clinical Trial 16
Nocturnal Home Hemodialysis System Product Patent Details 17
Product Institution Details 21
Non PVC CAPD 22
Non PVC CAPD Product Status 22
Non PVC CAPD Product Description 22
Non PVC CAPD Product Patent Details 22
TACHOSIL Fibrin Patch - Liver 26
TACHOSIL Fibrin Patch - Liver Product Status 26
TACHOSIL Fibrin Patch - Liver Product Description 26
TACHOSIL Fibrin Patch - Neurology 27
TACHOSIL Fibrin Patch - Neurology Product Status 27
TACHOSIL Fibrin Patch - Neurology Product Description 27
TACHOSIL Fibrin Patch Vascular 28
TACHOSIL Fibrin Patch Vascular Product Status 28
TACHOSIL Fibrin Patch Vascular Product Description 28
Baxter International Inc. - Key Competitors 29
Baxter International Inc. - Key Employees 30
Baxter International Inc. - Key Employee Biographies 32
Baxter International Inc. - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 37
Baxter International Inc., Recent Developments 37
Oct 18, 2012: Baxter Reports Revenue Of $3.5 Billion In Q3 2012 37
Aug 01, 2012: Baxter Breaks Ground On $1 Billion Manufacturing Plant In Georgia, US 38
Jul 19, 2012: Baxter Announces Collaboration With Sanquin To Expand Capacity For Plasma Therapies 38
Jul 19, 2012: Baxter Reports Revenue Of $3.6 Billion In Q2 2012 38
May 25, 2012: Baxter Announces Low Glucose PD Solutions Favorably Impact Metabolic Measures Including Glycemic Control In Trials Of Diabetics Undergoing Dialysis 39
Apr 19, 2012: Baxter To Build New Manufacturing Facility In Georgia To Support Growth Of Its Plasma-Based Treatments 40
Apr 19, 2012: Baxter Reports Revenue Of $3.4 Billion In Q1 2012 40
Jan 26, 2012: Baxter Reports Revenue Of $13.9 Billion In 2011 41
Jan 09, 2012: Baxter Appoints Jean-Luc Butel As President, International 42
Jan 09, 2012: Baxter Appoints Jean-Luc Butel As President 42

Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Table


Baxter International Inc., Key Facts 1
Baxter International Inc. Key Pipeline Products by Equipment Type 1
Baxter International Inc. Key Pipeline Products by Development Stage 1
Baxter International Inc. Key Pipeline Products by Trial Phase 1
Baxter International Inc., Key Facts 6
Baxter International Inc., Major Products and Services 7
Baxter International Inc. Number of Pipeline Products by Equipment Type 8
Baxter International Inc. Pipeline Products by Equipment Type 9
Baxter International Inc. Number of Pipeline Products by Development Stage 10
Baxter International Inc. Pipeline Products by Development Stage 11
Baxter International Inc. Number of Pipeline Products by Trial Phase 12
Baxter International Inc. Pipeline Products by Trial Phase 12
Baxter International Inc. Number of Pipeline Products By Milestone Summary 13
Baxter International Inc. Pipeline Products by Milestone Summary 14
Nocturnal Home Hemodialysis System - Product Status 15
Nocturnal Home Hemodialysis System - Product Description 15
Nocturnal Home Hemodialysis System - Product Milestone 15
Nocturnal Home Hemodialysis System - Efficacy Study Of Home Hemodialysis System To Assess Device Performance And Safety In Patients Undergoing Hemodialysis 16
Nocturnal Home Hemodialysis System - Patent Details1 17
Nocturnal Home Hemodialysis System - Patent Details2 17
Nocturnal Home Hemodialysis System - Patent Details3 18
Nocturnal Home Hemodialysis System - Patent Details4 18
Nocturnal Home Hemodialysis System - Patent Details5 19
Nocturnal Home Hemodialysis System - Patent Details6 20
Nocturnal Home Hemodialysis System - Patent Details7 20
Non PVC CAPD - Product Status 22
Non PVC CAPD - Product Description 22
Non PVC CAPD - Patent Details1 22
Non PVC CAPD - Patent Details2 23
Non PVC CAPD - Patent Details3 23
Non PVC CAPD - Patent Details4 24
Non PVC CAPD - Patent Details5 24
Non PVC CAPD - Patent Details6 24
Non PVC CAPD - Patent Details7 25
TACHOSIL Fibrin Patch - Liver - Product Status 26
TACHOSIL Fibrin Patch - Liver - Product Description 26
TACHOSIL Fibrin Patch - Neurology - Product Status 27
TACHOSIL Fibrin Patch - Neurology - Product Description 27
TACHOSIL Fibrin Patch Vascular - Product Status 28
TACHOSIL Fibrin Patch Vascular - Product Description 28
Baxter International Inc., Key Employees 30
Baxter International Inc., Key Employee Biographies 32
Baxter International Inc., Other Locations 33
Baxter International Inc., Subsidiaries 33

List of Chart


Baxter International Inc. Key Pipeline Products by Equipment Type 1
Baxter International Inc. Pipeline Products by Equipment Type 8
Baxter International Inc. Pipeline Products by Development Stage 10
Baxter International Inc. Pipeline Products by Trial Phase 12
Baxter International Inc. Pipeline Products by Milestone Summary 13

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *